Stop illegal marketing of drugs and devices

On this page

Illegal marketing

Advertising must be compliant with Canadian laws.

Specific laws apply to drug and device advertisements. The legislation consists of the:

Health Canada is responsible for ensuring compliance with the legislation and regulations. Only drugs and devices that have been authorized for sale by Health Canada may be advertised in Canada.

Advertising of drugs and devices to health care providers is prohibited if the claims:

Health product advertising is the direct or indirect promotion for the sale or use of any drug or device. This can be done by any means including:

Video

Stop Illegal Marketing of Drugs and Devices Program

Poster to share

Help stop illegal marketing of drugs and devices

Print the poster

The impact of illegal marketing

Illegal marketing may:

When making decisions about treatments for patients, health care providers use many different information sources. These include marketing materials provided by the pharmaceutical industry. It is important that these industry materials accurately convey the benefits and risks of their health products.

How opioid marketing contributes to the opioid crisis

In Canada, opioids are commonly obtained through prescriptions written by health care providers. Prescription opioids can help Canadians who need them to manage pain. However, the opioid crisis has shown the devastating effects that problematic use of opioids can have on families and communities across Canada.

There is value in the pharmaceutical industry conveying educational and scientific information about opioids to health care providers. However, marketing of opioids can unduly influence health care providers. We are taking action to address industry's marketing practices that are false, deceptive or misleading. For more information, visit our Restricting the Marketing and Advertising of Opioids page.

What we are doing to stop illegal marketing

We are working to support health care providers in identifying:

To help protect Canadians from the impact of illegal marketing, we:

Proactive monitoring of health product advertising

Health Canada has developed a proactive monitoring program for advertising drugs and devices. The initial focus is on opioid promotion.

The Health Canada team will:

We are sending a clear signal that illegal advertising of drugs and devices will not be tolerated.

The goal of the program is to prevent and address non-compliant advertising. The program will:

Raising awareness

To raise awareness of compliant versus non-compliant advertising, information on non-compliance will be shared with:

We are also considering introducing further restrictions on the advertising of opioids.

The advertising preclearance system

Health Canada encourages pharmaceutical manufacturers and advertisers to take advantage of the independent Canadian advertising preclearance system, except for opioids where it is mandatory.

This system helps advertisers develop promotional material that complies with the advertising provisions of:

The preclearance system is:

The Pharmaceutical Advertising Advisory Board (PAAB) provides review and preclearance services for all drugs advertised to health care providers that are submitted to them.

Extreme Reach and Ad Standards provide review and preclearance services for advertising related to consumer-directed products that are submitted to them, including:

Ad Standards also provides these services for:

The goal of preclearance is for promotional materials to be:

Both PAAB and Ad Standards provide advisory opinions on:

They do this with the goal that the advertising meets regulatory requirements.

How you can report illegal marketing

Report a marketing complaint

You report. You protect.

Page details

2020-05-20